Nasdaq · Biological Products, (No Diagnostic Substances)

Amgen Inc. (AMGN)

Amgen's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.

Track AMGN free

Last close

$478.09

+3.67% 1 day+61.4% 52 weeks

As of Nov 4, 2026, end of day (IEX). Not a live quote.

AMGN · one year of daily closes

Nov 3, 2025 to Nov 4, 2026 · end of day, split-adjusted

1-day change: +3.67%; From $461.15 the session before
52-week change: +61.4%; Close vs close ~252 sessions earlier
52-week range: $297.06–$478.09; Lowest and highest closing prices
Market cap: $249.4B; Last close × shares outstanding (SEC)
Revenue (TTM): $38.9B; 12 months to Sep 30, 2026
Net income (TTM): $9.4B; 12 months to Sep 30, 2026
Diluted EPS (TTM): $17.25; 12 months to Sep 30, 2026

Financials: trailing twelve months from Amgen’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Sep 30, 2026.

Recent SEC filings

Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All AMGN filings on EDGAR

Next earnings

~Feb 2, 2027Estimated

Past results were usually filed after the close

Estimated from past filing dates. Amgen hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.

Estimated from SEC EDGAR filing dates

Insider activity (last 90 days)

Open-market buys: 0; filings · 0 shares
Open-market sales: 3; filings · 10,112 shares

Source: SEC EDGAR Form 4, filed in the 90 days to Nov 5, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.

Insider share counts and prices are as reported on Form 4.

With a free Vero account

What Vero tracks about Amgen

Each new Amgen filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own AMGN, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.

Track AMGN free Write a thesis on AMGN

The free plan follows 3 stocks, with no card and no end date. Track AMGN with an AI agent

Amgen (AMGN): questions, answered from the data

When is Amgen's next earnings date?

Around Feb 2, 2027 (past results were usually filed after the close), but that is an estimate, not a date Amgen has announced. Estimated from past filing dates: Vero projects it from the dates of Amgen's past SEC filings (source: Estimated from SEC EDGAR filing dates). Treat it as approximate until the company confirms it.

What was AMGN's last closing price?

AMGN closed at $478.09 on Nov 4, 2026. This is an end-of-day price from trades on the IEX exchange, published the next trading day, not a live quote, and it can differ slightly from the consolidated official close. That was +3.67% from the session before and +61.4% over 52 weeks.

Have Amgen insiders bought or sold shares recently?

In the 90 days to Nov 5, 2026, SEC Form 4 shows 0 filings with open-market purchases (0 shares) and 3 filings with open-market sales (10,112 shares). The most recent: Khosla Rachna (SVP, Business Development) reported selling 3,252 shares, filed Aug 13, 2026. Grants, option exercises and tax withholding are not counted. Insider share counts and prices are as reported on Form 4.

What did Amgen file with the SEC most recently?

A 10-Q filed on Nov 4, 2026: Quarterly report for the period ended Sep 30, 2026. Before that, an 8-K on Nov 3, 2026 and an 8-K on Oct 27, 2026. Each filing is linked to the original on SEC EDGAR.

Is this page a recommendation to buy or sell AMGN?

No. It reports public data (end-of-day prices from IEX and filings from SEC EDGAR) with the date of each. Vero is a research tool, not a financial adviser, and nothing here is a recommendation to buy or sell any security.

Closes are end of day, as of each page’s date. Grouped by industry.

Sources and data notes

Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.

Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.

Data as of Nov 5, 2026.

AMGN · one year of daily closes

Key facts

Recent SEC filings

Next earnings

Insider activity (last 90 days)

What Vero tracks about Amgen

Amgen (AMGN): questions, answered from the data

Related companies

Cookies and tracking